glycoside. This compound can be considered as the promising for further studies on in vivo
modelsAKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) ,S-palladaheterocycle, inhibition of cytochromes P450 has been
modeled by molecular docking of four palladaheterocycle stereoisomers
LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) , we used the
model of CHF to elucidate the cardioprotective properties of PVSHE.
Methods. The active
of creating new
model objects with a given number of interacting dislocations has been shown.